# Translocator Protein and Inflammation After Traumatic Brain Injury

> **NCT01547780** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Institute of Mental Health (NIMH)** · enrollment: 52 (actual)

## Conditions studied

- Traumatic Brain Injury (TBI)
- Healthy

## Interventions

- **DRUG:** [11C]PBR28 and Positron Emission Tomography (PET)

## Key facts

- **NCT ID:** NCT01547780
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01-20
- **Primary completion:** 2017-09-28
- **Final completion:** 2017-09-28
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2021-07-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01547780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01547780, "Translocator Protein and Inflammation After Traumatic Brain Injury". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01547780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*